These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 23208700)
1. Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer. Sörensen J; Owenius R; Lax M; Johansson S Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):394-402. PubMed ID: 23208700 [TBL] [Abstract][Full Text] [Related]
2. A PET/MRI study towards finding the optimal [ Elschot M; Selnæs KM; Sandsmark E; Krüger-Stokke B; Størkersen Ø; Tessem MB; Moestue SA; Bertilsson H; Bathen TF Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):695-703. PubMed ID: 27817158 [TBL] [Abstract][Full Text] [Related]
3. Phase IIa clinical study of [ Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267 [TBL] [Abstract][Full Text] [Related]
4. Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study. Tade FI; Cohen MA; Styblo TM; Odewole OA; Holbrook AI; Newell MS; Savir-Baruch B; Li X; Goodman MM; Nye JA; Schuster DM J Nucl Med; 2016 Sep; 57(9):1357-63. PubMed ID: 27056619 [TBL] [Abstract][Full Text] [Related]
5. Comparison of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid (anti-[18F]FACBC) accumulation in lymph node prostate cancer metastasis and lymphadenitis in rats. Kanagawa M; Doi Y; Oka S; Kobayashi R; Nakata N; Toyama M; Shirakami Y Nucl Med Biol; 2014 Aug; 41(7):545-51. PubMed ID: 24816330 [TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
7. Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis. Turkbey B; Mena E; Shih J; Pinto PA; Merino MJ; Lindenberg ML; Bernardo M; McKinney YL; Adler S; Owenius R; Choyke PL; Kurdziel KA Radiology; 2014 Mar; 270(3):849-56. PubMed ID: 24475804 [TBL] [Abstract][Full Text] [Related]
8. Characterising Scott NP; Teoh EJ; Flight H; Jones BE; Niederer J; Mustata L; MacLean GM; Roy PG; Remoundos DD; Snell C; Liu C; Gleeson FV; Harris AL; Lord SR; McGowan DR Br J Cancer; 2022 Mar; 126(4):598-605. PubMed ID: 34795409 [TBL] [Abstract][Full Text] [Related]
9. [(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells. Ono M; Oka S; Okudaira H; Nakanishi T; Mizokami A; Kobayashi M; Schuster DM; Goodman MM; Shirakami Y; Kawai K Nucl Med Biol; 2015 Nov; 42(11):887-92. PubMed ID: 26278491 [TBL] [Abstract][Full Text] [Related]
10. Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using Miller MP; Kostakoglu L; Pryma D; Yu JQ; Chau A; Perlman E; Clarke B; Rosen D; Ward P J Nucl Med; 2017 Oct; 58(10):1596-1602. PubMed ID: 28385791 [No Abstract] [Full Text] [Related]
11. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial. Schreibmann E; Schuster DM; Rossi PJ; Shelton J; Cooper S; Jani AB Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):206-13. PubMed ID: 27511856 [TBL] [Abstract][Full Text] [Related]